Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hemispherx BioPharma, which is engaged in the manufacture and clinical development of new drug entities for the treatment of viral and immune-based disorders, has elected Thomas Equels, president and managing director of the Equels Law Firm, to its board of directors.
Subscribe to our email newsletter
Prior to his board election, Mr Equels served as Hemispherx BioPharma’s litigation counsel. Mr Equels’s legal practice is devoted to litigation, with particular emphasis on civil racketeering, business torts and commercial matters.
For more than 25 years, Mr Equels has represented national and state governments, and companies in the banking, insurance, aviation, pharmaceutical, construction and development industries.